A novel transcatheter mitral valve replacement system designed for left atrial fixation rather than subvalvular fixation ...
The Sapien M3 transcatheter mitral valve replacement system won FDA approval -- making it the first on the market to utilize a transseptal approach -- for the treatment of symptomatic ...
Patients undergoing transcatheter mitral valve replacement (TMVR) who receive direct oral anticoagulants (DOACs) have fewer bleeding and thrombotic events and shorter hospital stays than those taking ...
DENVER, CO—It’s early days, and the studies are small, but two new reports highlight the feasibility of transcatheter mitral valve replacement (TMVR) in patients with severe symptomatic mitral ...
Medicare reimbursement for transcatheter mitral valve repair (TMVR) was extended to include secondary (functional) mitral regurgitation resulting from heart failure, according to a revised National ...
The MITHRAS randomized clinical trial found that interventional closure of an iatrogenic atrial septal defect (iASD) driven by transcatheter mitral valve repair (TMVR) was not superior to conservative ...
IRVINE, Calif. — ReValve Solutions Inc. (ReValve), which has developed a next generation technology for Transcatheter Mitral Valve Replacement (TMVR), announced that an 81-year-old male, with a ...
A “minimalist” approach to transfemoral valve-in-valve transcatheter mitral valve replacement (TMVR), not unlike the approach commonly used with TAVI, appears to be safe and feasible when compared ...
A 2020 Focused Update of the 2017 Expert Consensus Decision Pathway on the Management of Mitral Regurgitation has been released to reflect new evidence in the field. The update, which is more of a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results